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Abstract
Background: During the process of metastasis, cells are subjected to various apoptotic stimuli.
Aberrant expression of apoptotic regulators often contribute to cell metastasis. Heat shock
protein 27(HSP27) is confirmed as an apoptosis regulator, but its antiapoptotic mechanism in
metastatic hepatocellular carcinoma (HCC) cells remains unclear.
Methods: Levels of HSP27 protein and its phosphorylation in Hep3B, MHCC97L to MHCC97H
cells with different metastatic potentials were determined by western blot analysis. MHCC97H
cells were transfected with specific small interference RNA (siRNA) against HSP27. The in vitro
migration and invasion potentials of cells were evaluated by Transwell assay. The apoptosis ratio of
MHCC97H cells was analyzed by TUNEL staining and Flow Cytometry. Alteration of signal
transduction pathway after HSP27 knockdown in MHCC97H cells was evaluated through a Human
Q Series Signal Transduction in Cancer Gene Array analysis. Nuclear NF-κB contentration and
endogenous IKK activity were demonstrated by ELISA assay. The association of IKKα, IKKβ, IκBα
with HSP27 and the association between IKKβ and IKKα in MHCC97H cells were determined by
co-immunoprecipitation assay followed by western blot analysis.
Results: HSP27 protein and its phosphorylation increased in parallel with enhanced metastatic
potentials of HCC cells. siRNA-mediated HSP27 knockdown in MHCC97H significantly suppressed
cells migration and invasion in vitro and induced cell apoptosis; the prominently altered signal
transduction pathway was NF-κB pathway after HSP27 knockdown in MHCC97H cells.
Furthermore, inhibition of HSP27 expression led to a significant decrease of nuclear NF-κB
contentration and endogenous IKK activity. In addition, HSP27 was associated with IKKα, IKKβ,
IκBα in three HCC cells above. ELISA assay and western blot analysis also showed a decrease of
the association between IKKβ and IKKα, the association between phosphor-HSP27 and IKK
complex, and an increase of total IκBα but reducing tendency of phosphor-IκBα when HSP27
expression was efficiently knocked down in MHCC97H cells.
Conclusion:  Altogether, these findings revealed a possible effect of HSP27 on apoptosis in
metastatic HCC cells, in which HSP27 may regulate NF-kB pathway activation.
Published: 31 March 2009
BMC Cancer 2009, 9:100 doi:10.1186/1471-2407-9-100
Received: 2 July 2008
Accepted: 31 March 2009
This article is available from: http://www.biomedcentral.com/1471-2407/9/100
© 2009 Guo et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
Page 2 of 10
(page number not for citation purposes)
Background
Metastasis is a complex process that requires the sequen-
tial completion of multiple steps in which various mole-
cules are involved [1]. During metastasis process, cells are
subjected to various apoptotic stimuli. Thus, in addition
to genetic changes that promote up-regulated prolifera-
tion, successful metastatic cells must have a decreased sen-
sitivity to apoptotic stimuli [2]. As many metastatic cancer
cells exhibit aberrations in levels and functions of key
apoptotic regulators, exploiting these alterations to
induce tumor cell apoptosis offers a promising therapeu-
tic target [3]. Numerous studies show that NF-κB has anti-
apoptotic effects which have been implicated in a variety
of biological processes [4]. The association of NF-κB path-
way activation with inflammation-associated/driven
tumor promotion, progression, and metastasis was dem-
onstrated in several mouse models [5]. It was found that
suppressing chronic NF-κB activation at later stages
resulted in the apoptotic death of transformed hepato-
cytes and failure to progress to hepatocellular carcinoma
[6].
Heat shock protein 27 (HSP27) is an ATP-independent
chaperone that confers protection against apoptosis
through various mechanisms, including interacting with
and inhibiting components of both stress and death-
receptor induced apoptotic pathways [7]. For example,
when overexpressed in response to various stimuli,
HSP27 facilitates phosphorylated IκBα proteasome medi-
ated proteolysis and enhances NF-κB activity, which could
account for its antiapoptotic properties [8]. Moreover,
increased levels of HSP27 expression may render tumours
more resistant to host defence mechanisms and increase
the metastatic potential of tumors cells [9]. Recently, our
previous study showed the important effect of HSP27 on
metastatic hepatocellular carcinoma (HCC) cells motility
[10]. These documents above suggest there may be an
internal mechanism which answers for regulation of
HSP27 on apoptosis in metastatic HCC cells.
In order to elucidate the assumption, in this study, we
demonstrated significant effects of HSP27 on HCC cells
motility and apoptosis in vitro. Analysis of the cDNA
microarray data revealed such effects may be related to the
regulation of HSP27 on NF-κB pathway activation in met-
astatic HCC cells, which was confirmed in further bio-
chemical investigation.
Methods
Cell culture
Hep3B cells were maintained in RPMI1640 medium
(Gibco-BRL, NY, USA) supplemented with 10% fetal
bovine serum (FBS). The other two HCC cell lines with
higher (MHCC97-H) and high (MHCC97-L) metastatic
potential were established in our institute [11]. Both cells
were cultured in high Glucose Dulbecco's modified
Eagle's medium (Gibco-BRL, NY, USA) supplemented
with 10% fetal calf serum at 37°C in a humidified atmos-
phere of 95% air and 5% CO2.
RNA interference
HSP27 siRNA duplex (sense:5'-ACGGUCAAGACCAAG-
GAUGdTdT-3'; antisense: 5'-CAUCCUUGGUCUUGAC-
CGUdTdT-3') were purchased from Cell Signaling
Technology. 2 × 106 cells were transfected with a final con-
centration (100 nM) of HSP27 siRNA using Lipo-
fectamine 2000 for 24 hr to detect mRNA level and for 48
hr to detect protein level in the presence of control or
HSP27 siRNA according to the manufacture instruction
(RNAi group), because siRNA duplex are generally
depleted in less than three days at when the interference
effect of siRNA will be weak. Lysates were prepared in lysis
buffer and equal amounts of protein were subjected to
immunoblot analysis. Cells which were transfected with
non-specific siRNA (MOCK group) or non-treated
MHCC97H cells (MHCC97H group) were parallelly dem-
onstrated.
RT-PCR of HSP27
The procedures of RT-PCR were the same as the previous
study [12]. Briefly, the total RNA of cells was extracted by
Trizol (Invitrogen). cDNA synthesis was performed in 20
μl reaction system of reverse transcription including 3 μg
RNA. Compound amplification of HSP27 and GAPDH
acting as internal control was then carried out using equal
cDNA as template. The sequence of primers is listed,
HSP27: 5'-ccagagcagagtcagccagcat-3'(sense), 5'-cgaaggt-
gactgggatggtga-3' (antisense); GAPDH: 5'-ccatgttcgtcat-
gggtgtgaacca-3' (sense), 5'-gccagtagaggcagggatgatgttc-3'
(antisense). The program of PCR: 95°C 30 s, 57°C 40 s,
72°C 40 s and 25 cycles were performed and PCR prod-
ucts were separated by 2% agarose gel electrophoresis,
then scanned and analyzed by VDS imagemaster system
(Pharmacia). Hsp27 primers used in this study yield an
expected single band (576 bp), GAPDH primers product
a 251 bp single band.
Western blot analysis
The cell total and nuclear proteins were lysed using pro-
tein extract kit (Active Motif, USA). SDS-PAGE was per-
formed in 12% polyacrylamide gel and proteins were
transferred for 1 hr using a Bio-Rad Semi-Dry apparatus in
a transfer buffer. After blocking for 1 hr with buffer (0.01
M PBS, 0.05% Tween-20 with 5% nonfat dry milk or 5%
BSA), PVDF membranes were probed with anti-HSP27
(Cell Signaling Technology, USA, 1:1000), anti-phospho-
HSP27 (Stressgen, USA, 1:1000), anti-activated NF-κB
p65 (Kangchen Biotech, China, 1:2000), anti-IKKβ (Cell
Signaling Technology, USA, 1:1000), anti-IKKα (Cell Sig-
naling Technology, USA, 1:1000), anti-IκBα (Cell Signal-BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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ing Technology, USA, 1:1000), anti-phospho-IκBα (Cell
Signaling Technology, USA, 1:1000) or anti-GAPDH
(Kangchen Biotech, China, 1:5000) overnight at 4°C, and
incubated with HRP-conjugated secondary antibody for 1
hr at room temperature. Peroxidase activity on the PVDF
membrane was visualized on X-ray film by means of the
ECL Western blotting detection system.
In vitro invasion and migration assay
In vitro invasion assay was performed using 24-well Tran-
swell unit with polycarbonate filters (Corning Costar,
Cambridge, MA). The HCC cells with RNAi treatments
were placed in the upper part of the Transwell, incubated
for indicated time, fixed with methanol, and stained with
hematoxylin for 10 min followed briefly by eosin. Cells in
the upper chamber were removed by cotton swab and the
cells that invaded through the Matrigel and were located
on the underside of the filter (16 fields/filter) were
counted. Three invasion chambers were used per condi-
tion. The values obtained were calculated by averaging the
total number of cells from three filters. Experimental pro-
cedures of in vitro migration assay are the same as the in
vitro invasion assay described above except that the filter
was not coated with Matrigel for the migration assay.
Analysis of apoptotic cells by TUNEL in situ detection and 
Flow Cytometry
Cells were cultured and treated with HSP27 siRNA for 24
hr. Fix air dried cell samples with a freshly prepared solu-
tion (4% paraformaldehyde in PBS, pH 7.4) for 1 hr at
15–25°C and incubate in permeabilisation solution
(0.1% Trixon X-100 in 0.1% sodium citrate) for 2 min on
ice. Then add 50 μl TUNEL (Roche) reaction mixture on
sample and incubate for 60 min at 37°C in a humidified
atmosphere in the dark. Samples can be analyzed in a
drop of PBS under a fluorescence microscope at this state.
In addition to TUNEL-staining, we attempted to confirm
apoptotic rates by FACS using 5,5-6,6-tetra-chloro-1,1-
3,3-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1,
Molecular Probes, Invitrogen Corporation, CA, USA)-
staining, because the loss of mitochondrial membrane
potential is an early indicator for apoptosis [13,14]. JC-1
staining solution was freshly prepared in a concentration
of 10 μg/mL prior to use with DMEM medium without
phenol red. Cells were cultured and treated with HSP27
siRNA for 24 hr. After washing with PBS (pH 7.4), 300 μL
staining solution was added and the cells were incubated
for 15 min at 37°C and 5% CO2 in the dark. Then washed
twice in PBS, and resuspended in 300 μl PBS. The cells
were then analyzed with a FACScan flow cytometer (Bec-
ton & Dickinson, Mountain View, CA, USA). JC-1 exhibits
potential-dependent accumulation in mitochondria, indi-
cated by a fluorescence emission shift from green (529
nm, FL1) to red (590 nm, FL2). In apoptotic cells, the
ratio of red to green fluorescence decreases if the mito-
chondrial membrane depolarizes.
cDNA microarray analysis
Total RNA was extracted from MHCC97H cells (1 × 106)
with different treatments (HSP27 RNAi group or MOCK
group) and without treatment (MHCC97H group) using
Trizol RNA extraction kit (Invitrogen). Q Series Signal
Transduction in Cancer Gene Array kit (SupperArray) was
used to detect the gene expression profile of signal trans-
duction pathways. Each array membrane comprised 96
marker genes in quatraplicate; four positive controls
including β-actin, GAPDH, cyclophilin A, and ribosomal
protein L13α; and a negative control, bacterial plasmid
pUC18. The linear normalization method was used for
data analysis, based on the expression levels of four posi-
tive controls in combination with bacterial plasmid
pUC18. Normalized data was log transformed and micro-
array spots in the t-test combined with ratio values double
difference were regarded as differentially expressed genes.
Measurement of nuclear NF-κB by ELISA
Nuclear extracts were prepared from treated and control
MHCC97H cells using a nuclear extraction kit (Active
Motif). Activated NF-κB in the samples was determined by
oligonucleotide-based ELISA (Active Motif). Treated and
control samples were normalized and incubated in 96-
well microtiter wells, and the activated NFκB in the
nuclear extracts attached to a consensus nucleotide
sequence (5'-GGGACTTTCC-3') that was coated onto the
microtiter wells. Attached NF-κB was captured by anti-
body to NF-κB (p65) and detected by an anti-rabbit-HRP-
conjugated IgG. Color development was performed with
hydrogen peroxide/TMB chromogenic substrate, and
intensity of the developed color proportionately repre-
sented the quantity of NFκB in each sample. The specifi-
city of the binding of NFκB of the samples with the
nucleotide sequence was determined by comparison to
the control binding, determined by adding either free con-
sensus nucleotide or mutated nucleotide to the reaction
buffer. The sample values were normalized with the total
cell protein determined by protein assay kit (Pierce).
Measurement of phospho-IκBα by ELISA
Total cell protein from each sample was normalized and
was same amount which had been subjected to ELISA
analysis. Phospho-IκBα ELISA kit that detects phosphor-
ylation of Serine 32 was from Cell Signaling Technology.
A mouse monoclonal antibody against IκBα was coated
onto the microwells of a 96-well plate into which same
amount lysates of various treated MHCC97H cells were
added. Phospho-IκBα in the cell lysate was captured by
the antibody, the wells were extensively washed, and a
second antibody was added to detect the captured phos-
pho(Ser32)-IκBα protein. An HRP linked anti-rabbit anti-BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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body was used to recognize the bound detection
antibody, and hydrogen peroxide/TMB was added for
color development. The optical density was proportional
to the quantity of phospho-IκBα protein present.
Co-immunoprecipitation Assay
Cells were rapidly trypsinized, and lysed by quick
repeated freeze-thawing cycles in distilled water contain-
ing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1
mM EGTA, 1% Triton X-100, 2.5 mM Sodium pyrophos-
phate, 1 mM β-glycerophosphate,1 mM PMSF, 1 μg/ml
Leupeptin. The cell lysate (1 mg total protein) was first
precleared and next incubated with the appropriate
HSP27 antibody (Cell Signaling Technology, USA, 10 μg),
IKKα antibody (Cell Signaling Technology, USA, 1:100)
and IKKβ antibody (Cell Signaling Technology, USA,
1:100) or goat anti-mouse/rabbit IgG1 (30 μg) (Sigma) at
4°C overnight. Protein G-Sepharose (20 μl) (Sigma) was
added and the mixture was incubated for an additional 1–
4 hr at 4°C. Samples were washed 3 times with buffer. The
immune complexes were eluted (100 μl) with 0.1 M gly-
cine pH 3.0 adjusted to pH 7.5 with Tris buffer and run on
a SDS-PAGE, then transferred to PVDF membrane for
western blot analysis.
IKK Assay
The detection of endogenous IKK activity in HCC cells was
described as the method below. Briefly, reactions were
performed in 50 μl reaction volumes in 96-well polysty-
rene plates with final conditions as follows: 25 mM Tris-
HCL (pH 7.5), 10 mM MgCL2, 5 mM β-glycerophosphate,
0.1 mM NaVO3, 2 mM DTT, 200 μM ATP, 1.5 μM biotin-
IκBα peptide, and the IKK complex which was immuno-
precipitated with anti- IKKα antibody(1:100). Reactions
were started with IKK complex addition, incubated at
room temperature for 15 min, 50 μl/well Stop Buffer (50
mM EDTA, pH 8) was added to stop the reaction. 25 μl of
each reaction was transferred to a 96-well streptavidin-
coated plate containing 75 μl dH2O/well and incubate at
room temperature for 60 min. The plate was washed and
incubated with 100 μl/well phosphor-IκBα mouse pri-
mary antibody (1:1000) at 37°C for 120 min, washed and
HRP labeled secondary antibody in PBS/T with 1% BSA
was added at room temperature for 30 min. After incu-
bated with TMB substrate for 15 min, washed and stop
solution was added. Plates were mixed well and read at
450 nm with a microtiter plate reader.
Statistical Analysis
Data were expressed as Mean ± SE and analyzed using
analysis of variance. Student's t-test was used in two-group
comparisons. P < 0.05 was considered to be statistically
significant.
Results
Up-regulated expression of HSP27 in metastatic HCC cells 
was positively correlated to HCC cell motility and invasion 
in vitro
To investigate the expression of HSP27 in Hep3B,
MHCC97L and MHCC97H cells respectively with non-,
high and higher metastatic potentials, we observed levels
of HSP27 expression and its phosphorylation in total pro-
teins of these HCC cells above through western blot anal-
ysis. The results showed that the level of HSP27 and basal
ratio of its phosphorylation were stepwise increased from
Hep3B to MHCC97L and MHCC97H cells (Fig. 1A), in
parallel with metastatic potentials.
To obtain insights into whether HSP27 was directly
related to HCC cells motility and invasion ability or not,
knockdown of HSP27 with small interference RNA
(siRNA) was performed in MHCC97H cells with higher
metastatic potential. Expression of HSP27 in MHCC97H
cells showed a significant decrease on the levels of mRNA
(Fig. 1B) and protein (Fig. 1C) in HSP27 RNAi group,
compared with MOCK group and control MHCC97H
group. The results indicated expression of HSP27 in
MHCC97H cells was efficiently inhibited. Then we
detected cells motility and invasion in the three groups
through in vitro migration and invasion assay. The results
showed that the number of HSP27-RNAi MHCC97H cells
through the filter (Migration assay: 98 ± 8; Invasion assay:
79 ± 7) was markedly less than the numbers of MOCK
cells (Migration assay: 191 ± 11; Invasion assay:201 ± 5)
and MHCC97H cells without any treatment (Migration
assay: 207 ± 10; Invasion assay:211 ± 4) (P < 0.05) (Fig.
1D). Thus, inhibition of HSP27 expression suppressed
significantly MHCC97H cells migration and invasion in
vitro.
Knockdown of HSP27 by siRNA induced significantly 
apoptosis of MHCC97H cells
It is well-recognized that HSP27 is an important regulator
of apoptosis pathways in cells [9]. Through TUNEL in situ
detection, we found that apoptosis ratio of cells increased
in MHCC97H cells after 24 hr treatment with siRNA
against HSP27 (Fig. 2A, B), compared with MOCK group
and MHCC97H cells group. In addition to TUNEL-stain-
ing, we attempted to reconfirm the apoptosis ratio of
HSP27-RNAi MHCC97H with 24 hr treatment by measur-
ing the mitochondrial membrane potential changes using
JC-1-staining, because the loss of mitochondrial mem-
brane potential is an early indicator for apoptosis[13,14].
It was shown that the percentage of apoptotic cells was
increased to 36.12% in RNAi group, compared with
17.13% in MOCK group and 12.12% in control
MHCC97H group (Fig. 2C). These results indicated inhi-
bition of HSP27 expression increased HCC cells apoptosis
ratio.BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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Different genes from cDNA microarray analysis were 
prominently related to NF-κB pathway after HSP27 
knockdown in MHCC97H cells
To investigate preferentially altered signal transduction
pathway in MHCC97H cells after HSP27 knockdown, the
Human Q Series Signal Transduction in Cancer Gene
Array including marker genes with functions related to
cell signal transduction pathways was used. Combined
with ratio values 2-fold difference, significantly down-reg-
ulated genes including NFKB1 (NFκB), IL2, NFKBIA
(IκBα), LTA, PECAM1 passed statistic t-test. The results
were reconfirmed by real-time PCR with different and spe-
cific primer pairs [see Additional file 1]. Through Pathway
Miner software analysis, these down-regulated genes indi-
cated the preferential change of NF-κB pathway after inhi-
bition of HSP27 expression in MHCC97H cells.
HSP27 was involved in NF-κB pathway activation in HCC 
cells
Microarray analysis results promoted us to elucidate a role
of HSP27 on activation of NF-κB pathway in HCC cells.
Firstly, after HSP27 knockdown, it was found that level of
activated NF-κB in nuclei decreased about 0.5-fold in
MHCC97H cells (Fig. 3A). Then, concentration of nuclear
NF-κB was detected in Hep3B, MHCC97L and MHCC97H
cells. It showed there was an increased tendency of nuclear
NF-κB concentration from Hep3B to MHCC97H cells
(Fig. 3B), which was identical to consecutively up-regu-
lated expression pattern of HSP27 in the three cell lines
(Fig. 1A). These results suggested that HSP27 may have an
effect on NF-κB activation in metastatic HCC cells.
To further confirmed this idea, immunoprecipitates from
Hep3B, MHCC97L and MHCC97H cells using HSP27
antibody were analyzed by SDS-PAGE, followed by west-
ern blot analysis with activated NF-κB p65, IKKα, IKKβ
and IκBα-specific antibodies. As shown in Fig. 4A, IKKα,
IKKβ and IκBα were detected out in the immunoprecipi-
tates, but not activated NF-κB p65. Further IKK assay anal-
ysis showed that IKK activity was highest in MHCC97H
cells, followed by MHCC97L cells and then Hep3B cells
(Fig. 4B), which was consistent with the elevated tendency
of NF-κB activation in the three HCC cell lines. In addi-
tion, phosphorylation of HSP27 in immunoprecipitates
from Hep3B, MHCC97L, MHCC97H cells was deter-
mined by western blot analysis with IKKα antibody, it was
found that phosphorylated HSP27 which was associated
with IKK complex reduced from Hep3B, MHCC97L to
MHCC97H cells (Fig. 4C).
Expression of HSP27 was distinctly inhibited after RNA interference Figure 1
Expression of HSP27 was distinctly inhibited after RNA interference. Levels of HSP27 and phosphorylated HSP27 in 
Hep3B, MHCC97L and MHCC97H cells were up-regulated through western blot analysis of whole cell lysate using specific 
antibodies (A). PCR products of HSP27 in MHCC97H after siRNA transfection for 24 hr (B) and its protein expression after 
siRNA transfection for 48 hr (C) were significantly reduced in MHCC97H cells. The values on bottom of the bands represent 
the densitometric estimation of the relative density of the band, calculated by comparing the ratio of intensity of MHCC97L 
and MHCC97H cell line with that of Hep3B cell line (the ratio in Hep3B was set as baseline 1.0). In addition, MHCC97H cells 
transfected with siRNA for 12 hr were subjected to in vitro migration and invasion assay (D) for 20 hr. The results represent 
means of triplicates; * statistically different from control at P < 0.05.BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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Apoptosis ratio of MHCC97H cells increased after HSP27 RNA interference Figure 2
Apoptosis ratio of MHCC97H cells increased after HSP27 RNA interference. MHCC97H cells apoptosis were 
detected TUNEL technology in situ in RNAi, MOCK and MHCC97H groups (A, B). In addition to TUNEL-staining, apoptotic 
rates were confirmed by Flow Cytometry using JC-1-staining (C). It showed the result with respect to an early indicator for 
apoptosis, the loss of mitochondrial membrane potential, was consistent with the result of TUNEL detection. Data are repre-
sentative of 3 separate experiments. * statistical difference from control at P < 0.05.BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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In addition, IKK activity reduced significantly (Fig. 4D)
and the association between IKKβ and IKKα decreased
(Fig. 4E) after HSP27 knockdown in MHCC97H cells,
compared with MOCK group. Moreover, it was shown
that protein level of total IκBα increased 1.3-fold (Fig. 4F),
but its phosphorylated level tended to slightly reduced
(0.8-fold) after HSP27 knockdown in MHCC97H cells,
compared with MOCK group cells (Fig. 4G).
Discussion
Although HSP27 is induced transiently after periods of
cell stress, it is often constitutively over-expressed in
tumor cells [9,15]. In addition, increased HSP27 is
responsible for the increase in experimental endothelial
cell metastasis and further associated with metastatic dis-
ease in breast and ovarian cancers [16,17]. Our previous
studies and this study showed that up-regulated expres-
sion of HSP27 was related to malignant potentials of HCC
cells [10,12,18], it suggested a role of HSP27 in HCC
development and progression.
It is hypothesized that tumor cells with elevated levels of
heat-shock proteins have a selective pro-survival advan-
tage that contributes to the process of tumorigenesis and
enhancement of malignant potentials. Moreover, the pre-
condition of gaining such advantages requires persistent
activation of proliferation signal or blockage of apoptosis
pathway [7,19]. It is also well-known that HSP27 is able
to block apoptosis at different stages because of its inter-
action with a number of partners implicated in the apop-
totic pathways [20,21]. Furthermore, the capacity of
HSP27 to interact with one or another partner seems to be
determined by the oligomerization/phosphorylation sta-
tus which is two activation forms of HSP27 [22-24].
Through flow cytometry and TUNEL label analysis, we
found that apoptotic ratio of metastatic HCC cells
increased significantly after inhibition of HSP27 expres-
sion. The data suggested an important role of up-regulated
HSP27 in inhibiting HCC cells apoptosis.
To elucidate the effect of up-regulated HSP27 on HCC
cells apoptosis, through a signal transduction cDNA
microarray analysis, we found that these significantly dif-
ferent genes were prominently related to NF-κB signal
transduction pathway in HCC cells. It seems likely that
regulation of HSP27 on NF-κB pathway activation is
involved in metastatic HCC cells apoptosis.
It is reported that IκB kinase/NF-κB (IKK/NF-κB) signal-
ing pathway plays critical roles in a variety of physiologi-
cal and pathological processes. During the process, the
control of IκBα phosphorylation in response to all other
NF-κB activating stimuli rests on the shoulders of the IκB
kinase (IKK) complex [25]. Moreover, the association of
NF-κB pathway activation with tumor promotion, pro-
gression, and metastasis was well documented [26]. In
diverse cell types, NF-κB signaling pathway has been
shown to have a critical role in regulating the apoptotic
program. Whether NF-κB promotes or inhibits apoptosis
appears to depend on the specific cell type and the type of
inducer [27]. In this research, we observed that activated
NF-κB in nuclei increased gradually from Hep3B,
MHCC97L to MHCC97H cells. It is accordance with some
studies in HCC [28]. More intriguingly, we have found
HSP27 was involved in activation of NF-kB pathway in HCC cell lines Figure 3
HSP27 was involved in activation of NF-kB pathway in HCC cell lines. Nuclear NF-κB concentration was analyzed by 
ELISA in HSP27 RNAi, MOCK and MHCC97H cells (A) and in Hep3B, MHCC97L and MHCC97H cells (B). The values repre-
sent the relative intensity measured at 450 nm of these different treated cell lysates. The results represent means of triplicates. 
** statistical difference from control at P < 0.01.BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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that the level of nuclear activated NF-κB reduced after
HSP27 knockdown, indicating depletion of HSP27 inhib-
ited NF-κB pathway activation in HCC cells. It was
reported that, as a component of IKK complex, Hsp90/
Cdc37 was related to regulation of IKK activity, indicating
heat shock protein could be involved in regulation of NF-
κB signal pathway activation [29]. Therefore, we next
examined effects of HSP27 on key molecules of NF-κB
pathway.
We demonstrated that HSP27 was associated with IKKα,
IKKβ and IκBα in HCC cells. The result indicated that
effects of HSP27 on NF-κB pathway activation may be
from its interaction with IKKα, IKKβ and IκBα. It was also
found in this study that basal level of phosphorylated
HSP27 and IKK activity increased consecutively from
Hep3B to MHCC97L, MHCC97H cells, which was con-
sistent with activated NF-κB in nuclei. It suggested NF-κB
pathway activation may be IKK-dependent in our meta-
static HCC cell lines. In addition, IKK complex in HCC
cells was not only associated with phosphorylated HSP27,
but with non-phosphorylated HSP27, and it also showed
that phosphorylated HSP27 associated with IKK complex
reduced from Hep3B, MHCC97L to MHCC97H cells.
Therefore, it was possible that phosphorylation of HSP27
may have a negative effect on activation of IKK complex
through interacting with some intercellular kinases [30],
whereas non-phosphorylated HSP27 may maintain IKK
signalosome specific conformation or assist the IKK resol-
ubilization in HCC cells, which can be implied by sup-
pression of endogenous IKK complex activity in HSP27-
knockdown HCC cells. Alternatively, it has been reported
that HSP90 could regulate IKK receptiveness to post-trans-
lational modification or even the activity of enzymes that
carry out such modifications [31]. Whether HSP27 plays
such a role in HCC cells needs further study.
In addition, our findings also showed, after HSP27 deple-
tion by siRNA, the level of total IκBα mildly increased but
its phosphorylated ratio showed a reduced tendency in
HCC cells. It suggested that HSP27 may play dual roles in
IκBα degradation, not only favors a proteasome complex
for IκBα degradation through direct association with
IκBα, but also enhances indirectly IκBα phosphorylation
through IKK complex.
Conclusion
In summary, the results reported in the present study sug-
gested at some extent the contribution of HSP27 to meta-
static HCC cells apoptosis, which involves more than one
single mechanism. Particularly relevant in this regard is
the regulation of HSP27 on key molecules of NF-κB sign-
aling pathway. This study provides a new insight for ana-
lyzing the role of HSP27 in HCC cells resistance against
apoptosis.
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HSP27 interacts with key molecular (IKKβ, IKKα, IκBα) of NF-kB pathway in HCC cell lines. The precipitated 
IKKβ, IKKα, IκBα with anti-HSP27 antibody or normal mouse IgG1 were detected by western blot analysis in Hep3B, 
MHCC97L and MHCC97H cells, the HSP27 contents in the precipitates were used as equal loading amount control (A). 
Endogenous IKK activity in Hep3B, MHCC97L and MHCC97H cells (B) and in RNAi, MOCK and MHCC97H cells (D) was 
detected through IKK assay. The absorbed value of reaction solution from MHCC97H cells or Hep3B cells served as a percent 
control. The precipitated HSP27 and phosphorylated HSP27 with IKK complex by using anti-IKKα antibody were detected in 
Hep3B, MHCC97L and MHCC97H cells, the IKKα contents in the precipitates were used as equal loading amount control (C). 
Moreover, the precipitated IKKβ with anti-IKKα antibody or precipitated IKKα with anti-IKKβ antibody and normal rabbit 
IgG1 in RNAi, MOCK and MHCC97H cells were demonstrated by western blot analysis and the association between IKKα 
and IKKβ was reduced. The IKKα or IKKβ contents in the precipitates were used as equal loading amount control (E). In addi-
tion, total IκBα (F) and phosphorylated IκBα (G) were also analyzed by western blot analysis or ELISA in RNAi, MOCK and 
MHCC97H cells. The values on bottom of the bands represent the densitometric estimation of the relative density of the 
band. Data are representative of 3 separate experiments; * statistical difference from control at P < 0.05.BMC Cancer 2009, 9:100 http://www.biomedcentral.com/1471-2407/9/100
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